ALSBreakthrough - Khabar Asia

Breakthrough ALS Drug Tofersen Launches in China, Offering New Hope

Tofersen, a gene-targeted therapy for ALS caused by SOD1 mutations, is now available in China, offering hope for slowing disease progression.